Refine Search
(7)
(12)
(49)
(96)

Immunology

GlobalData provides unique and market-leading data and insights into the immunology market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

NEW Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

An allergy or allergic disease is a condition that arises from an adverse reaction to an exogenous antigen, a substance that invokes an immunological response. These conditions are extremely common. The number of people diagnosed with allergic ...

Drug Hypersensitivity Reactions Global Clinical Trials Review, H1, 2019

  • $2,500
  • May 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Drug Hypersensitivity Reactions Global Clinical Trials Review, H1, 2019" provides an overview of Drug Hypersensitivity Reactions clinical trials scenario. This report provides top line data relating...

Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Churg-Strauss Syndrome Global Clinical Trials Review, H1, 2019" provides an overview of Churg-Strauss Syndrome clinical trials scenario. This report provides top line data relating to the clinical t...

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Disco...

Chronic Inflammation Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Chronic Inflammation Global Clinical Trials Review, H1, 2019" provides an overview of Chronic Inflammation clinical trials scenario. This report provides top line data relating to the clinical trial...

Corneal Graft Rejection Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Corneal Graft Rejection Global Clinical Trials Review, H1, 2019" provides an overview of Corneal Graft Rejection clinical trials scenario. This report provides top line data relating to the clinical...

Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019

  • $2,500
  • April 2019
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cutaneous Lupus Erythematosus Global Clinical Trials Review, H1, 2019" provides an overview of Cutaneous Lupus Erythematosus clinical trials scenario. This report provides top line data relating to ...

Rheumatoid Arthritis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time.

In 2017, the diagnose...

Rheumatoid Arthritis: Epidemiology Forecast to 2027

  • $3,995
  • January 2019
Add to Basket Quick View Add to Saved List

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immu...

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

  • $10,995
  • December 2018
Add to Basket Quick View Add to Saved List

Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2–3% worldwide. The exact causes of psoriasis is unknown, although it is believed that environmental factors, skin barrier disruptions, and immune d...

Plaque Psoriasis: Epidemiology Forecast to 2027

  • $3,995
  • December 2018
Add to Basket Quick View Add to Saved List

Plaque psoriasis is a chronic immune-mediated skin disease characterized by red, flaky patches that are itchy and sometimes painful. Psoriatic plaques are formed due to an increased production of skin cells; normally the process to make and rep...

Cat Allergy Global Clinical Trials Review, H2, 2018

  • $2,500
  • December 2018
Add to Basket Quick View Add to Saved List

GlobalData's clinical trial report, “Cat Allergy Global Clinical Trials Review, H2, 2018" provides an overview of Cat Allergy clinical trials scenario. This report provides top line data relating to the clinical trials on Cat Allergy. ...

Competitor Landscape: Graft Versus Host Disease (GVHD)

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the graft versus host disease (GVHD) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Competitor Landscape: Sjögren's Syndrome

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren's Syndrome market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) fo...

Competitor Landscape: Systemic Sclerosis (Scleroderma)

  • $6,400
  • November 2018
Add to Basket Quick View Add to Saved List

Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Systemic Sclerosis (Scleroderma) market, analysis of current & potential future product positioning, and forecast approval dates (by q...

Join our mailing list
Find out first about the latest reports and offers.